French health authorities have officially recognized myalgic encephalomyelitis, widely known as chronic fatigue syndrome, on the Ameli health portal, removing long-standing psychiatric labels. The milestone update, published in August 2026 following international health guidelines, establishes post-exertional malaise as a core symptom for hundreds of thousands of affected adults.
An Institutional Shift on the Ameli Health Portal
France has formally updated its official medical stance on myalgic encephalomyelitis, better known as chronic fatigue syndrome. In a quiet but significant digital revision on the Ameli platform operated by the national health insurance fund, authorities removed all characterization of the condition as a psychological or psychiatric disorder. The updated documentation explicitly states that the illness must not be considered a psychological trouble, aligning national public health communications with contemporary international scientific standards.
For patient advocacy groups across the country, the digital rewrite marks the end of years spent navigating a medical system that frequently dismissed their physical symptoms. The update explicitly defines the pathology as an illness responsible for an invalidating chronic exhaustion and the onset of flare-ups following even minor physical or mental exertion.
Core Symptoms and the Danger of Graded Exercise
The revised health portal details a broad spectrum of clinical indicators that extend far beyond simple tiredness. While persistent, deep fatigue that is unresponsive to sleep remains a baseline marker, the guidance highlights post-exertional malaise as the central diagnostic symptom, alongside cognitive difficulties such as brain fog and memory disruptions.
Crucially, the updated guidance shifts away from outdated physical therapies. The health insurance fund removed prior recommendations that advocated for graded exercise therapy or structured physical retraining.
The Ameli website of the health insurance fund has just published a detailed page on ME/CFS. It notably recognizes post-exertional malaise as a central symptom, the different levels of severity, the importance of pacing [energy management] and the risks associated with graded exercise programs. Association française de l’encéphalomyélite myalgique et des intolérances systémiques à l’effort (AFEMISE)
Confronting the Psychologization of Illness
Medical consultations in France have long been characterized by skepticism toward patients suffering from chronic fatigue. Representatives from advocacy organizations point out that sufferers routinely faced institutional and clinical disbelief.
Pietro Tomé, president of the French association for myalgic encephalomyelitis, highlighted the psychological barriers patients encountered during routine medical visits, where symptoms were frequently attributed entirely to stress or lifestyle factors. It is really something we suffer from in a rather central way in France, Tomé noted regarding the persistent psychologization of the illness during doctor visits.
Chantal Somm, spokesperson for the advocacy group Millions Missing France, emphasized that the physical toll extends to basic daily functioning, noting that cognitive impairment and the inability to remain upright for sustained periods often leave individuals unable to perform routine tasks like grocery shopping.
Prevalence Estimates and the Post-Pandemic Surge
Measuring the exact scale of the condition in France remains difficult due to the absence of a national epidemiological study. Official health data indicates that roughly 200,000 adults were affected prior to the arrival of COVID-19. However, health authorities acknowledge that subsequent viral infections have driven caseloads significantly higher.
Independent patient organizations place the actual tally much higher than baseline governmental estimates. Millions Missing France suggests that the total number of impacted individuals could reach at least 700,000, or even more than a million, a substantial portion of whom remain undiagnosed or uncounted in official healthcare metrics.
Unresolved Challenges in Clinical Care
While the digital policy update provides formal institutional validation, concrete questions remain regarding daily clinical management and financial protection for patients. Because the exact physiological causes of the condition remain unknown, though frequently triggered by viral infections such as Epstein-Barr or coronavirus, medical practitioners still lack a targeted pharmacological cure.
Management relies entirely on symptom treatment, energy pacing, and adapted daily rhythms.
